Documente Academic
Documente Profesional
Documente Cultură
Symptoms
Signs and symptoms of bone cancer include:
Bone pain
Broken bone
Fatigue
Causes
Osteosarcoma
Ewing's sarcoma
It's not clear what causes most bone cancers. Doctors know bone cancer begins as an
error in a cell's DNA. The error tells the cell to grow and divide in an uncontrolled way.
These cells go on living, rather than dying at a set time. The accumulating mutated cells
form a mass (tumor) that can invade nearby structures or spread to other areas of the
body.
Types of bone cancer
Bone cancers are broken down into separate types based on the type of cell where the
cancer began. The most common types of bone cancer include:
Ewing's sarcoma. It's not clear where in bone Ewing's sarcoma begins, but the
tumors most commonly arise in the pelvis, legs or arms of children and young
adults.
Risk factors
It's not clear what causes bone cancer, but doctors have found certain factors are
associated with an increased risk, including:
Bone Cancer
Key Points
1.
With modern surgical techniques, 9 out of 10 people who have bone cancer
in an arm or leg may not need amputation.
Because bone cancer can come back after treatment, regular follow-up visits
are important.
People with bone cancer are encouraged to enroll in clinical trials (research
studies) that explore new treatments.
2.
Osteosarcoma, which arises from osteoid tissue in the bone. This tumor occurs
most often in the knee and upper arm (1).
The Ewing Sarcoma Family of Tumors (ESFTs), which usually occur in bone but
may also arise in soft tissue (muscle, fat, fibrous tissue, blood vessels, or other
supporting tissue). Scientists think that ESFTs arise from elements of
primitive nerve tissue in the bone or soft tissue (2). ESFTs occur most commonly
along the backbone and pelvis and in the legs and arms (3).
Other types of cancer that arise in soft tissue are called soft tissue sarcomas. They are not
bone cancer and are not described in this resource.
3.
4.
Osteosarcoma occurs most commonly between ages 10 and 19. However, people
over age 40 who have other conditions, such as Paget disease (a benign condition
characterized by abnormal development of new bone cells), are at increased risk
of developing this cancer.
Chondrosarcoma occurs mainly in older adults (over age 40). The risk increases
with advancing age. This disease rarely occurs in children and adolescents.
5.
ESFTs occur most often in children and adolescents under 19 years of age. Boys
are affected more often than girls. These tumors are extremely rare in African
American children.
6.
X-rays, which can show the location, size, and shape of a bone tumor. If x-rays
suggest that an abnormal area may be cancer, the doctor is likely to recommend
special imagingtests. Even if x-rays suggest that an abnormal area is benign, the
doctor may want to do further tests, especially if the patient is experiencing
unusual or persistent pain.
7.
Surgery is the usual treatment for bone cancer. The surgeon removes the entire
tumor with negative margins (no cancer cells are found at the edge or border of
the tissue removed during surgery). The surgeon may also use special surgical
techniques to minimize the amount of healthy tissue removed with the tumor.
Chemotherapy is the use of anticancer drugs to kill cancer cells. Patients who
have bone cancer usually receive a combination of anticancer drugs. However,
chemotherapy is not currently used to treat chondrosarcoma (1).
Radiation therapy, also called radiotherapy, involves the use of high-energy xrays to kill cancer cells. This treatment may be used in combination with surgery.
It is often used to treat chondrosarcoma, which cannot be treated with
chemotherapy, as well as ESFTs (1). It may also be used for patients who refuse
surgery.
o
8.
Cryosurgery is the use of liquid nitrogen to freeze and kill cancer cells. This
technique can sometimes be used instead of conventional surgery to destroy the
tumor (1).
9.
Are clinical trials (research studies) available for people with bone cancer?
Yes. Participation in clinical trials is an important treatment option for many people with
bone cancer. To develop new treatments and better ways to use current treatments, NCI, a
part of the National Institutes of Health, is sponsoring clinical trials in many hospitals and
cancer centers around the country. Clinical trials are a critical step in the development of
new methods of treatment. Before any new treatment can be recommended for general use,
doctors conduct clinical trials to find out whether the treatment is safe for patients and
effective against the disease.
People interested in taking part in a clinical trial should talk with their doctor. Information
about clinical trials is available from NCIs Cancer Information Service (CIS) at 18004
CANCER (18004226237) and in the NCI booklet Taking Part in Cancer Treatment
Research Studies. This booklet describes how research studies are carried out and explains
their possible benefits and risks. More information about clinical trials is available on
NCIs Clinical Trials page, which offers detailed information about specific ongoing studies
by linking to PDQ, NCIs comprehensive cancer information database. The CIS also
provides information from PDQ.
Selected References
1. Malawer MM, Helman LJ, O'Sullivan B. Sarcomas of bone. In: DeVita VT,
Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of
Oncology. Vol. 2. 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2004.
2. Pizzo P, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 4th
ed. Philadelphia: Lippincott Williams and Wilkins, 2002.
3. Ries LAG, Smith MA, Gurney JG, et al., editors. Cancer Incidence and Survival
among Children and Adolescents: United States SEER Program 1975-1999.
Bethesda, MD: National Cancer Institute, 1999.
4. Miller RW, Boice JD, Curtis RE. Bone cancer. In: Schottenfeld D, Fraumeni JF,
editors. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford
University Press, 1996.
5. American Cancer Society (2008). Cancer Facts and Figures 2008
GA: American Cancer Society. Retrieved March 13, 2008.
. Atlanta,
6. Fischbach FT, Dunning MB. A Manual of Laboratory and Diagnostic Tests. 7th
ed. Philadelphia: Lippincott Williams and Wilkins, 2004.
Related Resources
Metastatic Cancer
Bone Cancer
The hard outer layer of bones is made of compact (cortical) bone, which covers the lighter spongy
(trabecular) bone inside. The outside of the bone is covered with a layer of fibrous tissue
called periosteum. Some bones are hollow and have a space called the medullary cavity which contains
the soft tissue called bone marrow (discussed below). The tissue lining the medullary cavity is
called endosteum. At each end of the bone is a zone of a softer form of bone-like tissue called cartilage.
Cartilage is softer than bone but more firm than most tissues. It is made of a fibrous tissue matrix mixed
with a gel-like substance that does not contain much calcium.
Most bones start out as cartilage. The body then lays calcium down onto the cartilage to form bone. After
the bone is formed, some cartilage may remain at the ends to act as a cushion between bones. This
cartilage, along with ligaments and some other tissues connect bones to form a joint. In adults, cartilage is
mainly found at the end of some bones as part of a joint. It is also seen at the place in the chest where the
ribs meet the sternum (breastbone) and in parts of the face. The trachea (windpipe), larynx (voice box),
and the outer part of the ear are other structures that contain cartilage.
Bone itself is very hard and strong. Some bone is able to support as much as 12,000 pounds per square
inch. It takes as much as 1,200 to 1,800 pounds of pressure to break the femur (thigh bone). The bone
itself contains 2 kinds of cells. The osteoblast is the cell that lays down new bone, and the osteoclast is
the cell that dissolves old bone. Bone often looks as if it doesnt change much, but the truth is that it is
very active. Throughout our bodies, new bone is always forming while old bone is dissolving.
In some bones the marrow is only fatty tissue. The marrow in other bones is a mixture of fat cells and
blood-forming cells. The blood-forming cells produce red blood cells, white blood cells, and blood
platelets. Other cells in the marrow include plasma cells, fibroblasts, and reticuloendothelial cells.
Cells from any of these tissues can develop into a cancer.
These benign tumors are not discussed further in this document, which is limited to bone
cancers.
chondrosarcomas but then some parts of the tumor change into cells like those of a high-grade
sarcoma (such as high grade forms of malignant fibrous histiocytoma [HIS-tee-oh-sy-TOH-muh],
osteosarcoma, or fibrosarcoma). This variant of chondrosarcoma tends to occur in older patients
and is more aggressive than usual chondrosarcomas.
Clear cell chondrosarcomas are rare and grow slowly. They rarely spread to other parts of the
body unless they have already come back several times in the original location.
Mesenchymal (meh-ZEN-kih-mul) chondrosarcomas can grow rapidly, but like Ewing tumor, are
sensitive to treatment with radiation and chemotherapy.
Ewing tumor: Ewing tumor is the third most common primary bone cancer, and the second most
common in children, adolescents, and young adults. This cancer (also called Ewing sarcoma) is named
after the doctor who first described it in 1921, Dr. James Ewing. Most Ewing tumors develop in bones, but
they can start in other tissues and organs. The most common sites for this cancer are the pelvis, the
chest wall (such as the ribs or shoulder blades), and the long bones of the legs or arms. This cancer is
most common in children and teenagers and is rare in adults older than 30. Ewing tumors occur most
often in white people and are very rare among African Americans and Asian Americans. More detailed
information about this cancer can be found in our document called Ewing Family of Tumors.
Malignant fibrous histiocytoma: Malignant fibrous histiocytoma (MFH) more often starts in soft tissue
(connective tissues such as ligaments, tendons, fat, and muscle) than in bones. This cancer is also
known as pleomorphic undifferentiated sarcoma, especially when it starts in soft tissues. When MFH
occurs in bones, it usually affects the legs (often around the knees) or arms. This cancer most often
occurs in elderly and middle-aged adults and is rare among children. MFH mostly tends to grow locally,
but it can spread to distant sites, like the lungs.
Fibrosarcoma: This is another type of cancer that develops more often in soft tissues than it does in
bones. Fibrosarcoma usually occurs in elderly and middle-aged adults. Bones in the legs, arms, and jaw
are most often affected.
Giant cell tumor of bone: This type of primary bone tumor has benign and malignant forms. The benign
(non-cancerous) form is most common. Giant cell bone tumors typically affect the leg (usually near the
knees) or arm bones of young and middle-aged adults. They dont often spread to distant sites, but tend
to come back where they started after surgery (this is called local recurrence). This can happen several
times. With each recurrence, the tumor becomes more likely to spread to other parts of the body. Rarely,
a malignant giant cell bone tumor spreads to other parts of the body without first recurring locally.
Chordoma: This primary tumor of bone usually occurs in the base of the skull and bones of the spine. It
develops most often in adults older than 30, and is about twice as common in men as in women.
Chordomas tend to grow slowly and often do not spread to other parts of the body, but they often come
back in the same area if they are not removed completely. The lymph nodes, the lungs, and the liver are
the most common areas for secondary tumor spread.
Multiple myelomas
Multiple myeloma almost always develops in bones, but doctors do not consider it a primary bone cancer
because it develops from the plasma cells of the bone marrow (the soft inner part of some bones).
Although it causes bone destruction, it is no more a bone cancer than is leukemia. It is treated as a
widespread disease. At times, myeloma can be first found as a single tumor (called a plasmacytoma) in a
single bone, but most of the time it will spread to the marrow of other bones. For more information see our
document Multiple Myeloma.